Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10 9 /L to <100 × 10 9 /L) at baseline: the final analysis of EXPAND.
Paola GuglielmelliJean-Jacques KiladjianAlessandro M VannucchiMinghui DuanHaitao MengLing PanGuang-Sheng HeSrdan VerstovsekFrançoise BoyerFiorenza BarracoDietger NiederwieserEster PungolinoAnna Marina LiberatiClaire HarrisonPantelia RoussouMonika WroclawskaDivyadeep KarumanchiKaren SinclairPeter A W Te BoekhorstHeinz GisslingerPublished in: Therapeutic advances in hematology (2022)
ClinicalTrials.gov NCT01317875.
Keyphrases